The Closed System Drug Transfer Device Market is dominated by hospitals and clinics, which represented approximately 79% of the market in 2025. Hospitals remain the primary setting for hazardous-drug preparation and chemotherapy administration.

Specialty oncology centers are expected to be among the fastest-growing end-user categories, supported by the expansion of dedicated cancer-treatment facilities and high-volume compounding operations.

Centralized compounding pharmacies and outsourcing facilities also represent an important opportunity. Standardized environments with large preparation volumes can benefit from consistent closed-system workflows and automated safety processes.

Home-infusion services may provide another growth avenue as selected therapies increasingly move beyond traditional hospital environments. Compact, easy-to-use systems could support safer hazardous-drug handling in decentralized settings.